Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Lamivudine Stavudine & Nevirapine Tablets bulk supplier for pharma manufacturers

Lamivudine Stavudine & Nevirapine Tablets 150mg + 40mg + 200mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 150mg + 40mg + 200mg

Reference Brands: -

Category: Anti Viral

Lamivudine, stavudine and nevirapine 150/40/200 mg tablets, an older fixed-dose HIV regimen now rarely used. For HIV programmes and licensed importers in markets where it is still registered.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Lamivudine Stavudine & Nevirapine Tablets? List it or send an offer →

Product Description:

This fixed-dose tablet once formed a complete antiretroviral regimen in one: lamivudine 150 mg and stavudine 40 mg, both nucleoside reverse transcriptase inhibitors, with nevirapine 200 mg, a non-nucleoside inhibitor that binds directly to HIV reverse transcriptase. Taken twice daily, it replaced three tablets with one. It is an HIV medicine, not a hepatitis product. The 40 mg stavudine strength is outdated: WHO first cut the adult stavudine dose to 30 mg to reduce toxicity, then advised phasing stavudine out.

WHO guidelines and major regulators have moved to safer regimens, mainly dolutegravir-based, so this combination is now rarely used and supplied only where it remains registered. Stavudine causes peripheral neuropathy, lipoatrophy, lactic acidosis and pancreatitis. Nevirapine can cause severe rash, including Stevens-Johnson syndrome, and serious liver toxicity, especially early in treatment. It also needs a two-week once-daily lead-in, which this fixed tablet cannot provide, and it interacts with rifampicin and hormonal contraceptives. Patients still taking it should be reviewed for a switch.

Sourcing notes. Before ordering, confirm the product still holds a valid registration in the destination country and that the 40 mg stavudine strength is acceptable to the prescriber, since current national guidelines may no longer list it. Tender rules often require WHO prequalification or stringent-authority approval; ask for documentary evidence and its current status. Request a CoA per batch for all three actives, the GMP certificate, a CoPP and zone IVb stability data. Bottles with desiccant are the usual pack, with no cold chain. State quantity and the remaining shelf life you require.

Lamivudine Stavudine & Nevirapine Tablets — third party manufacturing & bulk supply

Lamivudine Stavudine & Nevirapine Tablets 150mg + 40mg + 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lamivudine Stavudine & Nevirapine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lamivudine Stavudine & Nevirapine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lamivudine Stavudine & Nevirapine Tablet... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Lamivudine Stavudine & Nevirapine Tablets is listed as Tablets in 150mg + 40mg + 200mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Lamivudine Stavudine & Nevirapine Tablets is referenced against -. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Valacyclovir Tablets

Strength:
500 mg, 1000 mg

Form: Tablets

Reference Brands: Valtrex (USA/EU/UK), Zelitrex (EU)

View Details
Lamivudine Stavudine & Nevirapine Tablets

Strength:
150mg + 30mg + 200mg

Form: Tablets

Reference Brands: -

View Details
Famciclovir Tablets

Strength:
125mg, 250 mg, 500 mg

Form: Tablets

Reference Brands: Famvir (USA/EU),

View Details
Ganciclovir Capsules

Strength:
250 mg

Form: Capsules

Reference Brands: Cytovene (USA/EU)

View Details
Valganciclovir Tablets

Strength:
450mg

Form: Tablets

Reference Brands: Valcyte (USA/EU/UK), Rovalcyte

View Details
Abacavir Sulphate Tablets

Strength:
300 mg, 600 mg

Form: Tablets

Reference Brands: Ziagen (USA/EU)

View Details
Atazanavir & Ritonavir Tablets

Strength:
300 mg + 100 mg

Form: Tablets

Reference Brands: -

View Details
Lamivudine & Zidovudine Tablets

Strength:
150mg + 300mg

Form: Tablets

Reference Brands: Combivir (USA/EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us